SEC Filing Details
Document Details
Form
Filing Date
May 1, 2026
Document Date
Apr 23, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Fulcrum Therapeutics
Issuer
Fulcrum Therapeutics, Inc.
Filer
Lehrer-Graiwer Joshua